Children with certain comorbidities and immunocompromising conditions are highly vulnerable to SARS-CoV-2 infection.
Vaccination against
SARS-CoV-2 is an important strategy to reduce
death,
critical illness and overall
disease burden. With the evolving and increasing
transmission of
SARS-CoV-2, universal
vaccination is essential to achieve this
goal.
Children with special medical conditions are considered as the priorities for
SARS-CoV-2 vaccination. However,
vaccine hesitancy towards the implementation of
SARS-CoV-2 vaccination currently remains an urgent challenge. In order to promote the sustainable
vaccination for those
children in Shanghai as well as
China, Shanghai municipal
center for disease control and prevention, together with the national
children’s medical center,
children’s
hospital of Fudan
university and the expert group on
immunization planning of the Shanghai
preventive medicine association, organized a
consensus expert working group to formulate the evidence-based recommendations and implementation
suggestions for
children with common
chronic diseases,
allergy history,
diseases involving adverse events related to
vaccination, and immunocompromising conditions, based on the published evidence of
SARS-CoV-2 vaccination for
populations and
children with special medical conditions.